🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/07/2004 | 42,74 | 43,46 | 42,65 | 43,28 | +1,73% | 1,90% | 7.717.158 |
| 21/07/2004 | 43,18 | 43,70 | 42,55 | 42,55 | -0,54% | 2,67% | 7.868.803 |
| 20/07/2004 | 42,46 | 42,92 | 42,29 | 42,78 | +0,85% | 1,48% | 7.977.271 |
| 19/07/2004 | 42,75 | 42,88 | 42,27 | 42,41 | -0,78% | 1,43% | 5.755.511 |
| 16/07/2004 | 42,89 | 42,94 | 42,22 | 42,75 | +0,20% | 1,67% | 6.832.017 |
| 15/07/2004 | 43,53 | 43,79 | 42,65 | 42,66 | -2,12% | 2,61% | 5.740.001 |
| 14/07/2004 | 43,46 | 43,99 | 43,46 | 43,59 | +0,29% | 1,21% | 5.390.807 |
| 13/07/2004 | 43,60 | 43,65 | 43,27 | 43,46 | -0,26% | 0,88% | 3.820.274 |
| 12/07/2004 | 43,76 | 43,85 | 43,23 | 43,58 | -0,41% | 1,42% | 4.658.779 |
| 09/07/2004 | 43,94 | 44,15 | 43,65 | 43,76 | -0,13% | 1,15% | 4.315.035 |
| 08/07/2004 | 43,75 | 44,64 | 43,75 | 43,82 | -0,84% | 2,03% | 6.199.444 |
| 07/07/2004 | 44,38 | 44,54 | 43,98 | 44,19 | -0,62% | 1,27% | 4.955.154 |
| 06/07/2004 | 44,71 | 44,90 | 44,43 | 44,47 | -0,55% | 1,05% | 4.311.053 |
| 02/07/2004 | 45,13 | 45,19 | 44,68 | 44,71 | -0,40% | 1,14% | 3.377.494 |
| 01/07/2004 | 45,47 | 45,54 | 44,38 | 44,90 | -0,95% | 2,56% | 7.113.195 |
| 30/06/2004 | 45,32 | 45,52 | 44,76 | 45,32 | +0,32% | 1,66% | 6.176.598 |
| 29/06/2004 | 44,97 | 45,55 | 44,90 | 45,18 | +0,45% | 1,46% | 4.052.721 |
| 28/06/2004 | 45,13 | 45,21 | 44,84 | 44,98 | +0,30% | 0,82% | 4.960.289 |
| 25/06/2004 | 45,73 | 45,80 | 44,85 | 44,85 | -1,90% | 2,09% | 6.978.632 |
| 24/06/2004 | 45,65 | 46,20 | 45,43 | 45,72 | +0,21% | 1,69% | 4.425.914 |
| 23/06/2004 | 45,29 | 45,71 | 44,99 | 45,62 | +0,46% | 1,58% | 6.243.041 |
| 22/06/2004 | 45,52 | 45,73 | 45,23 | 45,41 | -0,75% | 1,11% | 5.421.723 |
| 21/06/2004 | 45,90 | 46,28 | 45,73 | 45,75 | -0,85% | 1,21% | 4.344.484 |
| 18/06/2004 | 46,12 | 46,55 | 46,02 | 46,15 | +0,08% | 1,14% | 8.639.398 |
| 17/06/2004 | 45,92 | 46,26 | 45,73 | 46,11 | +0,50% | 1,16% | 4.337.672 |
| 16/06/2004 | 45,99 | 46,25 | 45,85 | 45,88 | +0,27% | 0,87% | 5.480.935 |
| 15/06/2004 | 45,18 | 45,93 | 45,04 | 45,75 | +2,24% | 1,96% | 7.871.842 |
| 14/06/2004 | 45,35 | 45,44 | 44,73 | 44,75 | -1,84% | 1,56% | 6.899.822 |
| 10/06/2004 | 45,43 | 45,61 | 45,10 | 45,59 | -0,15% | 1,13% | 4.395.102 |
| 09/06/2004 | 45,90 | 46,16 | 45,63 | 45,66 | -1,08% | 1,16% | 3.959.868 |